🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 15 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/02/2021 | 167,00 | 171,77 | 166,56 | 168,55 | +1,37% | 3,12% | 279.300 |
| 09/02/2021 | 169,88 | 170,52 | 166,04 | 166,28 | -1,78% | 2,64% | 201.400 |
| 08/02/2021 | 170,07 | 170,50 | 168,26 | 169,30 | -0,25% | 1,32% | 192.300 |
| 05/02/2021 | 169,88 | 170,51 | 165,44 | 169,72 | +1,13% | 2,98% | 169.900 |
| 04/02/2021 | 170,46 | 171,10 | 167,09 | 167,83 | -1,23% | 2,35% | 158.500 |
| 03/02/2021 | 170,48 | 172,36 | 169,52 | 169,92 | +0,06% | 1,67% | 147.000 |
| 02/02/2021 | 169,07 | 171,93 | 168,81 | 169,81 | +0,95% | 1,85% | 263.500 |
| 01/02/2021 | 170,08 | 170,58 | 164,36 | 168,22 | +2,69% | 3,66% | 214.700 |
| 29/01/2021 | 165,25 | 167,26 | 162,26 | 163,82 | -0,35% | 3,03% | 221.500 |
| 28/01/2021 | 156,61 | 165,15 | 156,61 | 164,39 | +5,52% | 5,45% | 338.500 |
| 27/01/2021 | 163,81 | 163,81 | 153,92 | 155,79 | -5,50% | 6,04% | 561.100 |
| 26/01/2021 | 170,09 | 170,09 | 163,40 | 164,85 | -2,66% | 3,93% | 225.600 |
| 25/01/2021 | 168,53 | 169,45 | 165,00 | 169,35 | +0,98% | 2,64% | 154.000 |
| 22/01/2021 | 166,73 | 168,89 | 164,47 | 167,71 | +0,34% | 2,65% | 203.500 |
| 21/01/2021 | 170,99 | 171,19 | 166,95 | 167,14 | -2,35% | 2,48% | 260.600 |
| 20/01/2021 | 174,84 | 176,23 | 170,25 | 171,17 | -0,26% | 3,42% | 345.100 |
| 19/01/2021 | 174,23 | 176,31 | 170,52 | 171,61 | -0,70% | 3,32% | 276.600 |
| 15/01/2021 | 165,70 | 173,72 | 165,70 | 172,82 | +3,32% | 4,84% | 719.200 |
| 14/01/2021 | 163,31 | 168,31 | 162,37 | 167,26 | +3,18% | 3,64% | 366.200 |
| 13/01/2021 | 163,96 | 164,38 | 160,50 | 162,11 | -1,28% | 2,37% | 308.500 |
| 12/01/2021 | 168,62 | 169,60 | 162,58 | 164,21 | -2,27% | 4,16% | 283.200 |
| 11/01/2021 | 166,08 | 171,17 | 164,30 | 168,03 | +1,79% | 4,14% | 538.800 |
| 08/01/2021 | 167,75 | 168,21 | 163,76 | 165,08 | -1,18% | 2,65% | 442.000 |
| 07/01/2021 | 165,07 | 170,26 | 164,17 | 167,05 | +2,17% | 3,69% | 664.900 |
| 06/01/2021 | 156,15 | 164,04 | 156,15 | 163,51 | +4,30% | 5,05% | 637.700 |
| 05/01/2021 | 153,94 | 157,20 | 153,67 | 156,77 | +1,84% | 2,29% | 355.800 |
| 04/01/2021 | 151,79 | 154,43 | 150,73 | 153,94 | +1,42% | 2,44% | 329.300 |
| 31/12/2020 | 149,00 | 152,82 | 145,79 | 151,79 | +2,09% | 4,72% | 351.800 |
| 30/12/2020 | 150,28 | 151,67 | 148,58 | 148,68 | -0,58% | 2,06% | 226.600 |
| 29/12/2020 | 151,00 | 151,67 | 147,32 | 149,54 | -0,31% | 2,88% | 265.700 |